Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asad Bashey

Showing results (111-120 of 128) with videos related to

Pageof 13
Sort By:
Transplantation and Cellular Therapy|March 29, 2021
Impact of Pretransplantation Renal Dysfunction on Outcomes after Allogeneic Hematopoietic Cell TransplantationNosha Farhadfar, Ajoy Dias, Tao Wang, et al.
Cancer|April 13, 2018
Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failureSonali M Smith, James Godfrey, Kwang Woo Ahn, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 31, 2006
Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remissionMartin S Tallman, Waleska S Pérez, Hillard M Lazarus, et al.
The New England Journal of Medicine|May 11, 2012
Lenalidomide after stem-cell transplantation for multiple myelomaPhilip L McCarthy, Kouros Owzar, Craig C Hofmeister, et al.
Blood Advances|February 28, 2019
The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemiaMoshe Yeshurun, Daniel Weisdorf, Jacob M Rowe, et al.
The Lancet. Haematology|August 23, 2017
Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trialSarah A Holstein, Sin-Ho Jung, Paul G Richardson, et al.
Leukemia|April 22, 2020
Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current eraBinod Dhakal, Sagar Patel, Saulius Girnius, et al.
Ejhaem|May 29, 2025
Efficacy of Total-Body Irradiation-based Intensified Myeloablative Regimens for Acute Leukemia-An International Collaborative StudyYasuyuki Arai, Ruta Brazauskas, Naya He, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 20, 2016
Maintenance versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple MyelomaRobert F Cornell, Anita D'Souza, Adetola A Kassim, et al.
Transplantation and Cellular Therapy|August 17, 2021
Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic SyndromesBetül Oran, Kwang Woo Ahn, Caitrin Fretham, et al.
Pageof 13

Showing results (111-120 of 128) with videos related to

Sort By:
Pageof 13
Transplantation and Cellular Therapy|March 29, 2021
Impact of Pretransplantation Renal Dysfunction on Outcomes after Allogeneic Hematopoietic Cell TransplantationNosha Farhadfar, Ajoy Dias, Tao Wang, et al.
Cancer|April 13, 2018
Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failureSonali M Smith, James Godfrey, Kwang Woo Ahn, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 31, 2006
Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remissionMartin S Tallman, Waleska S Pérez, Hillard M Lazarus, et al.
The New England Journal of Medicine|May 11, 2012
Lenalidomide after stem-cell transplantation for multiple myelomaPhilip L McCarthy, Kouros Owzar, Craig C Hofmeister, et al.
Blood Advances|February 28, 2019
The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemiaMoshe Yeshurun, Daniel Weisdorf, Jacob M Rowe, et al.
The Lancet. Haematology|August 23, 2017
Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trialSarah A Holstein, Sin-Ho Jung, Paul G Richardson, et al.
Leukemia|April 22, 2020
Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current eraBinod Dhakal, Sagar Patel, Saulius Girnius, et al.
Ejhaem|May 29, 2025
Efficacy of Total-Body Irradiation-based Intensified Myeloablative Regimens for Acute Leukemia-An International Collaborative StudyYasuyuki Arai, Ruta Brazauskas, Naya He, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 20, 2016
Maintenance versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple MyelomaRobert F Cornell, Anita D'Souza, Adetola A Kassim, et al.
Transplantation and Cellular Therapy|August 17, 2021
Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic SyndromesBetül Oran, Kwang Woo Ahn, Caitrin Fretham, et al.
Pageof 13